127 related articles for article (PubMed ID: 37846125)
1. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in Gastric Cancer.
Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
Zhang L; Liang X; Li Y
Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
[TBL] [Abstract][Full Text] [Related]
4. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
6. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
8. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
Sun M; Xia R; Jin F; Xu T; Liu Z; De W; Liu X
Tumour Biol; 2014 Feb; 35(2):1065-73. PubMed ID: 24006224
[TBL] [Abstract][Full Text] [Related]
9. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.
Wei GH; Wang X
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3850-3856. PubMed ID: 28975980
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression.
Peng W; Si S; Zhang Q; Li C; Zhao F; Wang F; Yu J; Ma R
J Exp Clin Cancer Res; 2015 Aug; 34(1):79. PubMed ID: 26253106
[TBL] [Abstract][Full Text] [Related]
14. miR-665 promotes the progression of gastric adenocarcinoma via elevating FAK activation through targeting SOCS3 and is negatively regulated by lncRNA MEG3.
Tang H; Long Q; Zhuang K; Yan Y; Han K; Guo H; Lu X
J Cell Physiol; 2020 May; 235(5):4709-4719. PubMed ID: 31650535
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
Sun KX; Wu DD; Chen S; Zhao Y; Zong ZH
Apoptosis; 2017 Dec; 22(12):1543-1552. PubMed ID: 29094270
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer.
Xu W; Ding M; Wang B; Cai Y; Guo C; Yuan C
Curr Med Chem; 2021; 28(42):8800-8809. PubMed ID: 34036905
[TBL] [Abstract][Full Text] [Related]
17. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer.
Ding L; Tian Y; Wang L; Bi M; Teng D; Hong S
Aging (Albany NY); 2019 Oct; 11(19):8139-8155. PubMed ID: 31584879
[TBL] [Abstract][Full Text] [Related]
19. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling.
Ma J; Li TF; Han XW; Yuan HF
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1513-1523. PubMed ID: 30990378
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
